Chemiesynth (Vapi) Ltd.

Chemiesynth (Vapi) Ltd.

BBSE:CHEMIESYNT
125.96
INR
+5.99
(+4.99%)
-3.64EPS
205.34MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
36.19
16.68
9.9
42.98
35.39
46.92
64.27
98.01
67.55
52.81
61.97
69.37
70.54
Basic EPS, GAAP
-3.15
-1.77
-0.59
1.29
3.82
4.26
11.6
8.85
1.81
-1.26
-0.35
-3.22
-3.64
Free Cash Flow per Basic Share
-0.8
-5.34
-1.15
-1.22
2.3
-7.08
-3.59
-0.54
-9.89
-6.15
1.61
-3.78
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
9.1
7.17
6.58
7.87
11.69
15.95
27.55
36.39
38.2
36.94
35.77
32.75
- -
Tangible Book Value per Share
8.95
7.02
6.43
7.87
11.69
15.95
27.55
36.39
38.2
36.94
35.77
32.75
- -
Basic Weighted Avg Shares
3
3
3
3
3
3
3
3
3
3
3
3
3
Sales/Revenue/Turnover
111
51
30
131
109
144
197
301
207
163
188
213
217
Operating Margin (%)
-6.33
-6.65
-8.55
0.95
13.65
12.08
24.31
8.43
6.77
1.51
4.3
-0.25
-0.87
Depreciation Expense
3
2
2
5
5
5
8
11
12
13
14
14
14
Net Income, GAAP
-10
-5
-2
4
12
13
36
27
6
-4
-1
-10
-11
Effective Tax Rate (%)
- -
- -
- -
- -
19.4
17.2
17.84
29.62
31.75
- -
- -
- -
- -
Profit Margin (%)
-8.72
-10.62
-5.96
3
10.79
9.08
18.05
9.03
2.68
-2.39
-0.56
-4.64
-5.16
Working Capital
-15
-6
-8
-2
-4
-21
-32
-31
-38
-47
-63
-87
- -
LT Debt
56
70
69
69
69
69
90
75
84
86
80
80
- -
Total Equity
28
22
20
24
36
49
85
112
117
113
110
101
- -
Return on Invested Capital (%)
- -
- -
- -
1.95
11.36
11.43
22.79
14.31
3.99
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
5.41
11.4
11.73
23.02
14.51
3.95
- -
- -
- -
- -
Return on Common Equity (%)
- -
-21.77
-8.59
17.79
39.1
30.81
53.35
27.67
4.85
-3.36
-0.95
-9.41
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
80
- -
LT Borrowings
- -
80
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
116
147
205

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
39
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
18
- -
Inventories
- -
19
- -
Total Current Liabilities
- -
126
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
80
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.13%
4.43%
-8.44%
Free Cash Flow
31.07%
225.77%
-338.8%
Net Income, GAAP
48.44%
97.49%
833.3%
Sales/Revenue/Turnover
37.27%
5.75%
13.57%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
29
55
39
67
188
2026
40
69
51
55
213
2027
42
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
-0.79
1.36
-1.53
0.61
-0.35
2026
-1.49
-1.43
-2.27
1.97
-3.22
2027
-1.9
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

Sector
Process industries
Industry
Chemicals: specialty
Address
Mumbai India
IPO Date
Jul 22, 2015
Business
Chemiesynth (Vapi) Ltd. is an India-based specialty chemicals manufacturing company primarily engaged in the custom synthesis, development, and production of dye intermediates, specialty chemicals, and fine organic compounds. Founded in 1986 and headquartered in Vapi, Gujarat, India, the company operates its primary chemical manufacturing and processing facility within the Gujarat Industrial Development Corporation (GIDC) industrial zone. Chemiesynth (Vapi) Ltd. provides a broad product and service portfolio across several core categories, including dye intermediates and synthetic color intermediates; specialty fine chemicals, including 2,5-dimethyl-2,5-hexanediol and 5-nitroisophthalic acid; industrial dyes and coloring agents, including fluorescent dyes, hair dye bases, fuel dyes, and chemical markers; and basic industrial organic chemicals, such as monochloroacetic acid and acetic acid derivatives. In addition to its catalog offerings, the company provides contract manufacturing, toll synthesis, process optimization, and chemical scale-up services for specialized applications. The company distributes its products on a business-to-business (B2B) basis to diverse downstream sectors, including the pharmaceutical industry for active pharmaceutical ingredient (API) synthesis; agrochemical manufacturing; cosmetics and personal care formulations; fragrance and aroma production; textile and paper processing; paints and coatings; and photographic chemical manufacturing. In recent corporate developments, Chemiesynth (Vapi) Ltd. has initiated strategic capital restructuring and financing programs to support business expansion and bolster operational working capital, including approving a proposal to expand its authorized share capital from INR 3.25 crore to INR 18.25 crore and approving the issuance of unlisted 5% Non-Convertible Cumulative Redeemable Preference Shares (NCRPS) on a private placement basis to raise up to INR 15 crore. In conjunction with these growth initiatives, the company has undertaken corporate governance updates comprising amendments to its Memorandum of Association (MOA) and the adoption of a revised set of Articles of Association (AOA).